Skip to main content
European Commission logo print header

A novel pharmaceutical treatment for nonalcoholic fatty liver disease

Publicaciones

miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression

Autores: Geula Hanin, Nadav Yayon, Yonat Tzur, Rotem Haviv, Estelle R Bennett, Shiran Udi, Yoganathan R Krishnamoorthy, Eleni Kotsiliti, Rivka Zangen, Ben Efron, Joseph Tam, Orit Pappo, Eyal Shteyer, Eli Pikarsky, Mathias Heikenwalder, David S Greenberg, Hermona Soreq
Publicado en: Gut, Issue 67/6, 2018, Page(s) 1124-1134, ISSN 0017-5749
Editor: BMJ Publishing Group
DOI: 10.1136/gutjnl-2016-312869

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles